SALEM PARTNERS
Salem Partners is a leading Los Angeles-based investment bank and wealth management firm. They build relationships using their judgment, objectivity and expertise to create significant long-term value for their clients.
SALEM PARTNERS
Social Links:
Founded:
1997-01-01
Status:
Active
Contact:
(310) 806-4200
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Font API Google Analytics LetsEncrypt Google Universal Analytics Domain Not Resolving Apache Microsoft Exchange Online Office 365 Mail ReCAPTCHA
Current Employees Featured
William B. Witte
William B. Witte President @ Salem Partners President
David Dodson
David Dodson Chief Investment Officer @ Salem Partners Chief Investment Officer
Goli Kamangar
Goli Kamangar Chief Compliance Officer and Director of Operations @ Salem Partners Chief Compliance Officer and Director of Operations
John Dyett
John Dyett Co-Founder and Managing Director @ Salem Partners Co-Founder and Managing Director
Ivar Combrinck
Ivar Combrinck Investment Banker - Media, Entertainment & Technology @ Salem Partners Investment Banker - Media, Entertainment & Technology 2016-05-01
Founder
John Dyett
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-07-09 | Onconano Medicine | Salem Partners investment in Series A - Onconano Medicine | 23.7 M USD |
2019-06-14 | Rightsline | Salem Partners investment in Series D - Rightsline | N/A |
2019-04-02 | Lucid Sight | Salem Partners investment in Series B - Lucid Sight | 6 M USD |
2018-11-13 | AsclepiX Therapeutics | Salem Partners investment in Convertible Note - AsclepiX Therapeutics | 5 M USD |
2018-05-17 | Onconano Medicine | Salem Partners investment in Series A - Onconano Medicine | 11.66 M USD |
2017-07-25 | Sebacia | Salem Partners investment in Series D - Sebacia | 20 M USD |
2016-05-16 | Lucid Sight | Salem Partners investment in Series A - Lucid Sight | 4.5 M USD |
2015-04-29 | Femasys | Salem Partners investment in Series B - Femasys | 10.2 M USD |
2014-03-05 | ZS Pharma | Salem Partners investment in Series D - ZS Pharma | 55 M USD |
2012-10-23 | ZS Pharma | Salem Partners investment in Series C - ZS Pharma | 46 M USD |